-
Information-Publications
-
PPTC7 acts as an essential co-factor of the SCFFBXL4 ubiquitin ligase complex to restrict BNIP3/BNIP3L-dependent mitophagyDetails -
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent InhibitorDetails -
FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinomaDetails -
Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinomaDetails -
Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G proteinDetails -
Developing PspCas13b-based enhanced RESCUE system, eRESCUE, with efficient RNA base editingDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
